Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
Titel:
Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
Auteur:
Lee, Sang Gyu Jee, Young Geon Chung, Hyun Chul Kim, Sung-Bae Ro, Jungsil Im, Young-Hyuck Im, Seock-Ah Seo, Jae Hong